Skip Navigation

European Heart Journal 1997 18(11):1755-1764;
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dunselman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunselman, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade

Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study

P. Dunselman*,, A. H. Liem{dagger}, G. Verdel{ddagger}, H. Kragten§, A. Bosma||, P. Bernink and on behalf of the FEMINA Study Group of the Working Group on Cardiovascular Research, The Netherlands (WCN)

*Ignatius Hospital, Breda and Department of Clinical Pharmacology, University of Groningen The Netherlands
{dagger}Oosterschelde Hospital Goes, The Netherlands
{ddagger}Kennemer Hospital Haarlem, The Netherlands
§de Wever Hospital Heerlen, The Netherlands
||St Joseph Hospital Veldhoven, The Netherlands
¶Martini Hospital Groningen, The Netherlands

Received 22 May 1997; accepted 30 May 1997.

Correspondence: Dr P. H. J. M. Dunselman, Ignatius Hospital, 21 Molengracht, 4818 CK Breda, The Netherlands

Abstract

AIMS: The study aimed to compare the addition of felodipine to metoprolol, and of the replacement of metoprolol by felodipine, with continuation of metoprolol, in patients with angina pectoris despite optimal beta-blockade.

METHODS AND RESULTS: The study was double-blind, parallel, randomized and controlled, and comprised 363 patients from 27 outpatient cardiology clinics in the Netherlands. The patients had angina and positive bicycle exercise tests despite optimal beta-blockade (resting heart rate <65 beats . min–1). Randomization was to three treatment groups: continuation of metoprolol (control), addition of felodipine to metoprolol, and replacement of metoprolol by felodipine. Exercise tests were repeated after 2 and 5 weeks. The main outcome measure was: exercise result after 5 weeks, compared with baseline, between-group comparison of changes vs control. There were no significant differences in exercise duration and onset of chest pain vs control. The addition of felodipine increased time until 1 mm ST depression (43 s, 95% confidence interval 20–65 s), and decreased both ST depression at highest comparable work load (0·46 mm, 95% confidence interval 0·19–0·72), and maximal ST depression (0·49 mm, 95% confidence interval 0·23–0·74). Exercise results after replacement of metoprolol by felodipine were not different from control, apart from a significant increase in rate pressure product. Significantly more patients experienced adverse events in the felodipine monotherapy group.

CONCLUSION: Combination of metoprolol and felodipine is to be preferred to felodipine monotherapy in patients who have signs and symptoms of myocardial ischaemia despite optimal beta-blockade.

Key Words: beta-blockers • calcium antagonists • dihydropyridines • metoprolol • felodipine • angina pectoris


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
C. Mannheimer, P. Camici, M.R. Chester, A. Collins, M. DeJongste, T. Eliasson, F. Follath, I. Hellemans, J. Herlitz, T. Luscher, et al.
The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina
Eur. Heart J., March 1, 2002; 23(5): 355 - 370.
[Full Text] [PDF]


Home page
Fam PractHome page
M. Eccles, N. Rousseau, P. Adams, and L. Thomas
Evidence-based guideline for the primary care management of stable angina
Fam. Pract., April 1, 2001; 18(2): 217 - 222.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. F. M. van den Heuvel, P. H. J. M. Dunselman, T. Kingma, P. Verhorst, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen
Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 470 - 474.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J.A.F.M. van der Vring, M.C.G. Daniels, N.J.H. Holwerda, P.J.A.M. Withagen, A. Schelling, T.J. Cleophas, and M.G.C. Hendriks
Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers
Angiology, June 1, 1999; 50(6): 447 - 454.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.